Adiponectin downregulates CD163 whose cellular and soluble forms are elevated in obesity

Daniela Sporrer, Markus Weber, Josef Wanninger, Johanna Weigert, Michael Neumeier, Fabian Stögbauer, Evelyn Lieberer, M. Bala, A. Kopp, Andréas Schäffler,

European Journal of Clinical Investigation · 2009 · 52 citations · 29 references

Abstract

This study indicates that monocytic CD163 and systemic sCD163 are elevated in T2D and obesity. Adiponectin reduces CD163 in vitro, but additional factors related to obesity like IL-6 may be more relevant in vivo.

References

29